Increased PD-L1 expression seen in the vast number of viruses that cause acute, chronic/persistent, and/or latent infections, as well as those that cause cancer, leads to the speculation of whether anti-PD-1/PD-L1 ICBs may be a possible therapy for viral infections. This evidence concerns the gene CD274 and cancer.